triumph retatrutide Breaking News top-line results of the TRIUMPH-4 study (retatrutide) Some Providers Prescribe Unapproved Retatrutide

The most common adverse reactions include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which occur as expected consequences of delayed gastric emptying and are typically transient

Injection site reactions are common, and the lack of standardised formulations means ingredient quality and sterility cannot be guaranteed outside regulated healthcare settings

doi: 10.1016/s0140-6736(03)14739-3 15 MillerAJArnoldAC

Notably, the study also found that longer use (over 22 weeks) was linked to weight reductions, and higher doses (around 1500 mg/day) were associated with smaller waistlines